Fawzy, A., Aly ELsersy, M., Kholeif, D., Aly, R. (2022). CD4/CD8 LYMPHOCYTE RATIO IN MILD AND MODERATE PREECLAMPSIA VERSUS NORMAL PREGNANCY. ALEXMED ePosters, 4(1), 27-28. doi: 10.21608/alexpo.2022.120585.1365
Abdelmoneim Ali Fawzy; Mervat Aly ELsersy; Dina Aly Kholeif; Reham Alaa El-Din Aly. "CD4/CD8 LYMPHOCYTE RATIO IN MILD AND MODERATE PREECLAMPSIA VERSUS NORMAL PREGNANCY". ALEXMED ePosters, 4, 1, 2022, 27-28. doi: 10.21608/alexpo.2022.120585.1365
Fawzy, A., Aly ELsersy, M., Kholeif, D., Aly, R. (2022). 'CD4/CD8 LYMPHOCYTE RATIO IN MILD AND MODERATE PREECLAMPSIA VERSUS NORMAL PREGNANCY', ALEXMED ePosters, 4(1), pp. 27-28. doi: 10.21608/alexpo.2022.120585.1365
Fawzy, A., Aly ELsersy, M., Kholeif, D., Aly, R. CD4/CD8 LYMPHOCYTE RATIO IN MILD AND MODERATE PREECLAMPSIA VERSUS NORMAL PREGNANCY. ALEXMED ePosters, 2022; 4(1): 27-28. doi: 10.21608/alexpo.2022.120585.1365
CD4/CD8 LYMPHOCYTE RATIO IN MILD AND MODERATE PREECLAMPSIA VERSUS NORMAL PREGNANCY
1Department of Obstetrics and Gynaecology , Faculty of Medicine, University of Alexandria, Egypt
2Department of Obstetrics and Gynecology, Faculty of Medicine, University of Alexandria.
3Department of Medical Microbiology and Immunology, Alexandria Faculty of Medicine, Alexandria University
4Department of Obstetrics and Gynecology, Faculty of Medicine, Alexandria University
Abstract
Introduction: Pre-eclampsia was found to complicates 2–8% of all pregnancies globally, and responsible for 9% of maternal mortatlity in Africa and Asia. Mild pre-eclampsia is defined according to the new classification set by the American College of Obstetrics and Gynecology as new-onset of high blood pressure of ≥ 140 to 159 mmHg systolic and/or 90 to 109 mmHg diastolic accompanied by proteinuria after 20 weeks of gestation. In recent years, the immunological role in the pathogenesis of PET was the scope for many researches. CD4/CD8 ratio is a blood laboratory test that can be considered as a measure of the patient's immune system's imbalance that captures important information about disease progress, it measures the ratio of two important subtypes of white blood cells namely; Cluster of differentiation 4 (CD4+), which are responsible for guarding against infections and Cluster of differentiation 8 (CD8+), which kill malignant cells and other noxious substances.